TY - JOUR T1 - Co-dydramol – specify the strength JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 38 LP - 39 DO - 10.1136/dtb.2018.4.0605 VL - 56 IS - 4 A2 - , Y1 - 2018/04/01 UR - http://dtb.bmj.com/content/56/4/38.2.abstract N2 - The Medicines and Healthcare Products Regulatory Agency (MHRA) has stressed the importance of specifying the strength of co-dydramol products when they are generically prescribed to minimise dispensing errors and the risk of accidental opioid overdose.1 The MHRA notes that the ratio of dihydrocodeine to paracetamol in co-dydramol was previously fixed at 1:50 (dihydrocodeine 10mg and paracetamol … ER -